دکتر هومن بهرمندی

1.       Hashemi H, Seyedian MA, Miraftab M, Bahrmandy H, Sabzevari A, Asgari S. Clinical results with two different pharmaceutical preparations of riboflavin in corneal cross-linking: an 18-month follow up. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 2015;23(1):4.

2.       Hashemi H, Miraftab M, Seyedian MA, Hafezi F, Bahrmandy H, Heidarian S, et al. Long-term Results of an Accelerated Corneal Cross-linking Protocol (18 mW/cm2) fortheTreatment of Progressive Keratoconus. American Journal of Ophthalmology. 2015.

3.       Hashemi H, Fotouhi A, Miraftab M, Bahrmandy H, Seyedian MA, Amanzadeh K, et al. Short-term comparison of accelerated and standard methods of corneal collagen crosslinking. J Cataract Refract Surg. 2015;41(3):533-40.

4.       Hashemi H, Seyedian MA, Miraftab M, Bahrmandy H, Sabzevari A, Asgari S. Comparison of clinical results of two pharmaceutical products of riboflavin in corneal collagen cross-linking for keratoconus. DARU, Journal of Pharmaceutical Sciences. 2014;22(1):37.